Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
ABAT 18 DIVALPROEX SODIUM CHEMBL2105613 inhibitor TdgClinicalTrial, TEND, TTD
ABAT 18 PYRUVATE CHEMBL1162144 inhibitor DrugBank, TTD 16435204, 11752352, 17355287
ABAT 18 L-ALANINE CHEMBL279597 inhibitor DrugBank, TTD 11752352, 17504214
ABAT 18 PYRIDOXAL PHOSPHATE CHEMBL82202 inhibitor DrugBank, TTD 16096275, 11752352, 14567543, 14534310, 17531224, 15723541
ABAT 18 VIGABATRIN CHEMBL89598 inhibitor TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, TEND, DrugBank, TTD 10503933, 10195585, 10530689, 11752352, 10206175, 10214744
ABAT 18 VALPROIC ACID CHEMBL109 TdgClinicalTrial, TEND
ABAT 18 L-GLUTAMATE CHEMBL575060 DrugBank 3299141, 17139284, 17016423, 1983997, 8979623
ABAT 18 TIAGABINE CHEMBL1027 TdgClinicalTrial, TEND
ABAT 18 CHEMBL378577 CHEMBL378577 inhibitor GuideToPharmacologyInteractions

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
ABAT rs1731017 AA + AG valproic acid efficacy no This was not significant after Bonferroni correction. Genotypes AA + AG is associated with increased resistance to valproic acid in people with Epilepsy as compared to genotype GG. 27918244 1448519661